Johnson & Johnson EBITDA 2010-2024 | JNJ

Johnson & Johnson EBITDA for the quarter ending September 30, 2024 was $5.669B, a 25.53% decline year-over-year.

  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.
  • Johnson & Johnson 2021 EBITDA was 26.804B, a 11.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Johnson & Johnson EBITDA 2010-2024 | JNJ

  • Johnson & Johnson 2023 EBITDA was 24.581B, a 9.28% decline from 2022.
  • Johnson & Johnson 2022 EBITDA was 27.095B, a 1.09% increase from 2021.
  • Johnson & Johnson 2021 EBITDA was 26.804B, a 11.5% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B